National Heart, Lung, and Blood Institute

"Administration of Virus-Specific Cytotoxic T-Lymphocytes for the Prophylaxis and Therapy of Adenovirus Infection post Allogeneic Stem Cell Transplant"

Lyptaist Protocol Version 11.0a (September 2006) - Lyptaist Protocol Consent Form (November 2006)

Clinical Trials.gov Identifier: NCT00590083

"Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV after Hemopoietic Stem Cell Transplantation (HSCT)"

Clinical Trials.gov Identifier: NCT00711035

CHALLAH Protocol

Sample Allo CTL Protocol Donor Consent

Sample Recipient Screening Consent Form

Sample Recipient Treatment Consent

Screening Consent Form

"A Phase I Study Evaluating the Use of Allodepleted T Cells Transduced with Inducible Caspase 9 Suicide Gene After Haploidentical Stem Cell Transplantation"

Clinical Trials.gov Identifier: NCT00710892

Caspallo Protocol

Back to Protocols

Page last updated on
November 2, 2009

Website maintained by: